Treatment Burden in Neovascular AMD: Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency

被引：28
|
作者：
Hussain, Rehan M. [1 ]
Hariprasad, Seenu M. [2 ]
Ciulla, Thomas A. [3 ]
机构：
[1] Bascom Palmer Eye Inst, 900 NW 17th St, Miami, FL 33136 USA
[2] Univ Chicago, Dept Ophthalmol & Visual Sci, 5841 S Maryland Ave,MC2114, Chicago, IL 60637 USA
[3] 200 W 103rd St, Indianapolis, IN 46290 USA
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2017年 / 48卷 / 10期
关键词：
MACULAR DEGENERATION; RANIBIZUMAB; EFFICACY; EXTEND; SAFETY; TRIAL;
D O I：
10.3928/23258160-20170928-01
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：780 / 784
页数：5
相关论文
共 50 条
  • [1] Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
    Wecker, Thomas
    Grundel, Bastian
    Reichl, Sabine
    Stech, Milena
    Lange, Clemens
    Agostini, Hansjuergen
    Boehringer, Daniel
    Stahl, Andreas
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [2] Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
    Thomas Wecker
    Bastian Grundel
    Sabine Reichl
    Milena Stech
    Clemens Lange
    Hansjürgen Agostini
    Daniel Böhringer
    Andreas Stahl
    Scientific Reports, 9
  • [3] A Meta-Analysis of Baseline Characteristics and Anti-VEGF Frequency for Neovascular AMD: Visual Acuity Gains are Influenced by Injection Frequency
    Hussain, Rehan M.
    Ciulla, Thomas A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [4] High-Frequency Anti-VEGF Treatment for Neovascular AMD
    Matthews, Dillion
    Kapoor, Kapil G.
    Wagner, Alan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [5] Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
    F G Holz
    R Tadayoni
    S Beatty
    A R Berger
    M G Cereda
    P Hykin
    G Staurenghi
    K Wittrup-Jensen
    J Nilsson
    K Kim
    S Sivaprasad
    Eye, 2016, 30 : 1063 - 1071
  • [6] Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
    Holz, F. G.
    Tadayoni, R.
    Beatty, S.
    Berger, A. R.
    Cereda, M. G.
    Hykin, P.
    Staurenghi, G.
    Wittrup-Jensen, K.
    Nilsson, J.
    Kim, K.
    Sivaprasad, S.
    EYE, 2016, 30 (08) : 1063 - 1071
  • [7] Driving vision in patients with neovascular AMD in anti-VEGF treatment
    Herlov Baselius, Nanna Jo
    Brynskov, Troels
    Falk, Mads Kruger
    Sorensen, Torben Lykke
    Subhi, Yousif
    ACTA OPHTHALMOLOGICA, 2021, 99 (08) : E1360 - E1365
  • [8] Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
    Veluswamy, Balaji
    Lee, Andy
    Mirza, Rukhsana G.
    Gill, Manjot K.
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 1565 - 1572
  • [9] Visual acuity outcomes of anti-VEGF treatment for neovascular age-related macular degeneration in clinical trials
    Yamashiro, Kenji
    Oishi, Akio
    Hata, Masayuki
    Takahashi, Ayako
    Tsujikawa, Akitaka
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2021, 65 (06) : 741 - 760
  • [10] Visual acuity outcomes of anti-VEGF treatment for neovascular age-related macular degeneration in clinical trials
    Kenji Yamashiro
    Akio Oishi
    Masayuki Hata
    Ayako Takahashi
    Akitaka Tsujikawa
    Japanese Journal of Ophthalmology, 2021, 65 : 741 - 760
12345